146 related articles for article (PubMed ID: 3373267)
21. [Results of cisplatin-based polychemotherapy and analysis of prognostic factors in ovarian cancer. Apropos of 106 cases].
Maloisel F; Dufour P; Bergerat JP; Bellocq JP; Duclos B; Boilletot A; Herbrecht R; Dellenbach P; Renaud R; Ritter P
Bull Cancer; 1989; 76(10):1083-93. PubMed ID: 2635636
[TBL] [Abstract][Full Text] [Related]
22. Ten-year outcome of patients with advanced epithelial ovarian carcinoma treated with cisplatin-based multimodality therapy.
Hoskins PJ; O'Reilly SE; Swenerton KD; Spinelli JJ; Fairey RN; Benedet JL
J Clin Oncol; 1992 Oct; 10(10):1561-8. PubMed ID: 1403035
[TBL] [Abstract][Full Text] [Related]
23. Consolidation with intraperitoneal cisplatin in first-line therapy of advanced ovarian cancer.
Beller U; Speyer J; Colombo N; Sorich J; Wernz J; Hochster H; Zeleniuch-Jacquotte A; Porges R; Beckman EM
J Clin Oncol; 1991 May; 9(5):809-17. PubMed ID: 2016624
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy consisting of cisplatin, doxorubicin and cyclophosphamide as an adjunct to surgery in stage Ic-II epithelial ovarian carcinoma. Gynecologic Oncology Group of the Comprehensive Cancer Center Limburg.
De Pree N; Wils J
Anticancer Res; 1989; 9(6):1873-5. PubMed ID: 2697191
[TBL] [Abstract][Full Text] [Related]
25. Cisplatin, carboplatin, and cyclophosphamide combination chemotherapy in advanced-stage ovarian carcinoma: an Eastern Cooperative Oncology Group pilot study.
Grem J; O'Dwyer P; Elson P; Simon N; Trump D; Frontiera M; Falkson G; Vogl S
J Clin Oncol; 1991 Oct; 9(10):1793-800. PubMed ID: 1919629
[TBL] [Abstract][Full Text] [Related]
26. Randomised comparison of cisplatin with cyclophosphamide/cisplatin and with cyclophosphamide/doxorubicin/cisplatin in advanced ovarian cancer. Gruppo Interegionale Cooperativo Oncologico Ginecologia.
Lancet; 1987 Aug; 2(8555):353-9. PubMed ID: 2886821
[TBL] [Abstract][Full Text] [Related]
27. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC).
Levenback C; Burke TW; Silva E; Morris M; Gershenson DM; Kavanagh JJ; Wharton JT
Gynecol Oncol; 1992 Sep; 46(3):317-21. PubMed ID: 1526508
[TBL] [Abstract][Full Text] [Related]
28. [Importance of clinically prognostic factors in the treatment of advanced ovarian carcinoma].
Albrecht M; Goepel E; Simon WE; Trams G
Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):482-7. PubMed ID: 2993094
[TBL] [Abstract][Full Text] [Related]
29. Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
Morris M; Gershenson DM; Burke TW; Kavanagh JJ; Silva EG; Wharton JT
Obstet Gynecol; 1990 Dec; 76(6):1020-4. PubMed ID: 2234710
[TBL] [Abstract][Full Text] [Related]
30. Long-term survival after chemotherapy with cisplatinum, adriamycin and cyclophosphamide for carcinoma of the ovary.
Davidson NG; Khanna S; Kirwan PH; Naftalin NJ; Roy UK; Chui D; Mitchell S
Clin Oncol (R Coll Radiol); 1990 Jul; 2(4):206-9. PubMed ID: 2261416
[TBL] [Abstract][Full Text] [Related]
31. Cisplatin (P) versus cyclophosphamide, adriamycin and cisplatin (CAP) for stage III-IV epithelial ovarian carcinoma: a prospective randomized trial.
Tomirotti M; Perrone S; Giè P; Canaletti R; Carpi A; Biasoli R; Lombardi F; Giovanninetti A; Mensi F; Villa S
Tumori; 1988 Oct; 74(5):573-7. PubMed ID: 3217992
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin-based chemotherapy in advanced ovarian cancer: initial experience in an Indian set-up.
Charak BS; Agarwala S; Gopal R; Advani SH; Nadkarni KS; Pai VR; Saikia TK; Desai PB
Indian J Cancer; 1989 Jun; 26(2):85-91. PubMed ID: 2592001
[TBL] [Abstract][Full Text] [Related]
33. Combined modality treatment for stage III ovarian carcinoma.
Rizel S; Biran S; Anteby SO; Brufman G; Sulkes A; Milwidsky A; Weshler Z; Fuks Z
Radiother Oncol; 1985 Apr; 3(3):237-44. PubMed ID: 2988025
[TBL] [Abstract][Full Text] [Related]
34. [The study of cyclic maintenance chemotherapy with cisplatin, adriamycin, and cyclophosphamide (cyclic PAC chemotherapy) in patients with advanced ovarian cancer].
Kobayashi H; Hayata T; Terao T; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):1936-42. PubMed ID: 2592816
[TBL] [Abstract][Full Text] [Related]
35. Cisplatin-containing versus cisplatin-free adjuvant chemotherapy in ovarian carcinoma. Results after second-look laparotomy.
Schneider J; Martin M; Erasun F; Matia JC; Rodriguez-Escudero FJ
Oncology; 1990; 47(2):109-11. PubMed ID: 2314822
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer.
Jacob JH; Gershenson DM; Morris M; Copeland LJ; Burke TW; Wharton JT
Gynecol Oncol; 1991 Aug; 42(2):146-50. PubMed ID: 1894174
[TBL] [Abstract][Full Text] [Related]
37. A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette-Guerin in patients with suboptimal stage III and IV ovarian cancer: a Gynecologic Oncology Group study.
Creasman WT; Omura GA; Brady MF; Yordan E; DiSaia PJ; Beecham J
Gynecol Oncol; 1990 Dec; 39(3):239-43. PubMed ID: 2258063
[TBL] [Abstract][Full Text] [Related]
38. Intraperitoneal cisplatin chemotherapy in ovarian carcinoma patients who are clinically in complete remission.
Menczer J; Ben-Baruch G; Rizel S; Brenner H
Gynecol Oncol; 1992 Aug; 46(2):222-5. PubMed ID: 1500025
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide as an adjunct to surgery in stage Ic-II epithelial ovarian carcinoma. Gynecologic Oncology Group of the Comprehensive Cancer Center.
Wils J; van Geuns H
Am J Clin Oncol; 1989 Jun; 12(3):251-4. PubMed ID: 2658540
[TBL] [Abstract][Full Text] [Related]
40. Treatment of advanced ovarian cancer with cisplatin, adriamycin and cyclophosphamide (PAC).
Diaz-Rubio E; Escudero M; Martin-Jimenez M; Vidart JA; Gonzalez-Larriba JL; Herraiz MA; Lopez Vega JM; Bullon F
Eur J Gynaecol Oncol; 1989; 10(6):424-32. PubMed ID: 2627975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
